BRIEF published on 01/15/2025 at 21:20, 10 months 20 days ago Park Crossing Dentistry Earns Esteemed "2024 Neighborhood Fave" Title Park Crossing Dentistry Neighborhood Fave 2024 Patient Recognition Charlotte Dental Care Trusted Dental Practice
BRIEF published on 01/15/2025 at 21:20, 10 months 20 days ago Park Crossing Dentistry remporte le titre prestigieux de « favori du quartier 2024 » Dentisterie Park Crossing Les Favoris Du Quartier 2024 Reconnaissance Des Patients Soins Dentaires À Charlotte Cabinet Dentaire De Confiance
PRESS RELEASE published on 01/15/2025 at 21:15, 10 months 20 days ago Park Crossing Dentistry Earns 2024 Neighborhood Fave Recognition on Nextdoor Park Crossing Dentistry named '2024 Neighborhood Fave' on Nextdoor in 'Best Medical Professional' category, highlighting exceptional patient care and commitment to beautiful smiles Patient Care Park Crossing Dentistry Neighborhood Fave Charlotte NC Dental Clinic
Published on 12/05/2025 at 02:35, 4 hours 47 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 22 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 17 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 22 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 22 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 52 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 31 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 57 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 7 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 7 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 22 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 22 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 37 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 37 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
